Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Beck, Dominik ^a,b   Ayers, Steve ^a   Wen, Jianguo ^c   Brandl, Miriam B ^a,b   Pham, Tuan D ^a   Webb, Paul ^a   Chang, Chung Che ^c   Zhou, Xiaobo ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PIWI INTERACTING RNA; RNA POLYMERASE II; TRANSFER RNA; UNTRANSLATED RNA; SMALL UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; BIOINFORMATICS; BONE MARROW CELL; CELL SCREENING; CONTROLLED STUDY; DNA DAMAGE; FEEDBACK SYSTEM; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RNA SEQUENCE; TRANSCRIPTION REGULATION; BIOLOGY; CHEMISTRY; CONFORMATION; EXON; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SEQUENCE ANALYSIS;

COMPUTATIONAL BIOLOGY; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MYELODYSPLASTIC SYNDROMES; NUCLEIC ACID CONFORMATION; RNA POLYMERASE II; RNA, SMALL UNTRANSLATED; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC;

EID: 79951849971     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-19     Document Type: Article

References (57)

1. Clinical and Economic Consequences of Myelodysplastic Syndromes in the United States: An Analysis of the Medicare Database. SL Goldberg N Mody-Patel ER Chen, ASH Annual Meeting Abstracts 2008 112 636-
2. Myelodysplastic syndromes: clinicopathologic features, pathobiology, and molecular pathogenesis. HT Nishino CC Chang, Arch Pathol Lab Med 2005 129 1299 1310 16196520 (Pubitemid 41407437)
3. Proposals for the classification of the myelodysplastic syndromes. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick C Sultan, Br J Haematol 1982 51 189 199 6952920 (Pubitemid 12073508)
4. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. JW Vardiman J Thiele DA Arber RD Brunning MJ Borowitz A Porwit NL Harris MM Le Beau E Hellstrom-Lindberg A Tefferi CD Bloomfield, Blood 2009 114 937 951 10.1182/blood-2009-03-209262 19357394
5. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). U Germing B Hildebrandt M Pfeilstocker T Nosslinger P Valent C Fonatsch M Lubbert D Haase C Steidl O Krieger,, et al. Leukemia 2005 19 2223 2231 10.1038/sj.leu.2403963 16193087 (Pubitemid 41741618)
6. Mechanisms of Disease: Myelodysplastic Syndromes. A Tefferi JW Vardiman, New England Journal of Medicine 2009 361 1872 1885 10.1056/NEJMra0902908 19890130
7. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. YO Huh I Jilani E Estey F Giles H Kantarjian E Freireich M Albitar, Leukemia 2002 16 2249 2252 10.1038/sj.leu.2402704 12399969 (Pubitemid 35331841)
8. Excessive apoptosis in low risk myelodysplastic syndromes (MDS). JE Parker GJ Mufti, Leuk Lymphoma 2000 40 1 24 10.3109/10428190009054877 11426609
9. Understanding the Myelodysplastic Syndromes. PA Kouides JM Bennett, Oncologist 1997 2 389 401 10388074 (Pubitemid 28028594)
10. Myelodysplasia. ML Heaney DW Golde, N Engl J Med 1999 340 1649 1660 10.1056/NEJM199905273402107 10341278 (Pubitemid 29249435)
11. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. JE Parker GJ Mufti F Rasool A Mijovic S Devereux A Pagliuca, Blood 2000 96 3932 3938 11090080
12. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. H Kurotaki Y Tsushima K Nagai S Yagihashi, Acta Haematol 2000 102 115 123 10.1159/000040984 10692673 (Pubitemid 30058099)
13. Angiogenesis in myelodysplastic syndromes (MDS) in Indian patients. P Dutta J Bhattacharya AK Karak M Gupta T Chatterjee U Srinivas P Mishra R Saxena, Indian J Pathol Microbiol 2006 49 218 220 16933718 (Pubitemid 44276691)
14. Prognostic evaluation of the microvascular network in myelodysplastic syndromes. P Korkolopoulou E Apostolidou PM Pavlopoulos N Kavantzas N Vyniou I Thymara E Terpos E Patsouris X Yataganas P Davaris, Leukemia 2001 15 1369 1376 10.1038/sj.leu.2402220 11516097 (Pubitemid 32785306)
15. The role of angiogenesis in the biology and therapy of myelodysplastic syndromes. A Aguayo, Curr Hematol Rep 2004 3 184 191 15087066
16. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. DT Starczynowski F Kuchenbauer B Argiropoulos S Sung R Morin A Muranyi M Hirst D Hogge M Marra RA Wells,, et al. Nat Med 2010 16 49 U84 10.1038/nm.2054 19898489
17. P054 MicroRNA expression profiling of high and low risk MDS. J Gaken A Mohamedali N Twine N Westwood B Czepulkowski S Chehade N Lea L Quek G Mufti, Leukemia Research 2009 33 90 S90 10.1016/S0145-2126(09)70134-1
18. RNA-Seq: a revolutionary tool for transcriptomics. Z Wang M Gerstein M Snyder, Nat Rev Genet 2009 10 57 63 10.1038/nrg2484 19015660
19. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. B Langmead C Trapnell M Pop SL Salzberg, Genome Biol 2009 10 25 10.1186/gb-2009-10-3-r25 19261174
20. An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development. S Paradis DB Harrar Y Lin AC Koon JL Hauser EC Griffith L Zhu LF Brass C Chen ME Greenberg, Neuron 2007 53 217 232 10.1016/j.neuron.2006.12.012 17224404 (Pubitemid 46074399)
21. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. RA Irizarry B Hobbs F Collin YD Beazer-Barclay KJ Antonellis U Scherf TP Speed, Biostatistics 2003 4 249 264 10.1093/ biostatistics/4.2.249 12925520
22. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. A Pellagatti M Cazzola A Giagounidis J Perry L Malcovati MG Della Porta M Jadersten S Killick A Verma CJ Norbury,, et al. Leukemia 2010 24 756 764 10.1038/leu.2010.31 20220779
23. VARNA: Interactive drawing and editing of the RNA secondary structure. K Darty A Denise Y Ponty, Bioinformatics 2009 25 1974 1975 10.1093/bioinformatics/ btp250 19398448
24. The microRNA.org resource: targets and expression. D Betel M Wilson A Gabow DS Marks C Sander, Nucleic Acids Res 2008 36 149 153 10.1093/nar/gkm995 18158296
25. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. BP Lewis CB Burge DP Bartel, Cell 2005 120 15 20 10.1016/j.cell.2004.12.035 15652477 (Pubitemid 40094598)
26. TRANSFAC: transcriptional regulation, from patterns to profiles. V Matys E Fricke R Geffers E Gossling M Haubrock R Hehl K Hornischer D Karas AE Kel OV Kel-Margoulis,, et al. Nucleic Acids Res 2003 31 374 378 10.1093/nar/gkg108 12520026 (Pubitemid 36150406)
27. The Universal Protein Resource (UniProt) in 2010. R Apweiler MJ Martin C O'Donovan M Magrane Y Alam-Faruque R Antunes D Barrell B Bely M Bingley D Binns,, et al. Nucleic Acids Research 2010 38 142 D148 10.1093/nar/gkp846 19843607
28. T Hastie R Tibshirani JH Friedman, The Elements of Statistical Learning: The Elements of Statistical Learning: Data Mining, Inference, and Prediction Springer Second 2009
29. Regularization Paths for Generalized Linear Models via Coordinate Descent. Tibshirani JHFaTHaR, Journal of Statistical Software 2010 33 1 22 20808728
30. The lasso method for variable selection in the Cox model. R Tibshirani, Stat Med 1997 16 385 395 10.1002/(SICI)1097-0258(19970228)16:4<385::AID- SIM380>3.0.CO;2-3 9044528 (Pubitemid 27073009)
31. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. RD Morin MD O'Connor M Griffith F Kuchenbauer A Delaney AL Prabhu Y Zhao H McDonald T Zeng M Hirst,, et al. Genome Res 2008 18 610 621 10.1101/gr.7179508 18285502 (Pubitemid 351482785)
32. miRBase: tools for microRNA genomics. S Griffiths-Jones HK Saini S van Dongen AJ Enright, Nucleic Acids Res 2008 36 154 158 10.1093/nar/gkm952 17991681
33. The UCSC Genome Browser database: update 2010. B Rhead D Karolchik RM Kuhn AS Hinrichs AS Zweig PA Fujita M Diekhans KE Smith KR Rosenbloom BJ Raney,, et al. Nucleic Acids Res 2010 38 613 619 10.1093/nar/gkp939 19906737
34. tRNA over-expression in breast cancer and functional consequences. M Pavon-Eternod S Gomes R Geslain Q Dai MR Rosner T Pan, Nucleic Acids Res 2009 37 7268 7280 10.1093/nar/gkp787 19783824
35. tRNA binds to cytochrome c and inhibits caspase activation. Y Mei J Yong H Liu Y Shi J Meinkoth G Dreyfuss X Yang, Mol Cell 2010 37 668 678 10.1016/j.molcel.2010.01.023 20227371
36. Transferring death: a role for tRNA in apoptosis regulation. BJ van Raam GS Salvesen, Mol Cell 2010 37 591 592 10.1016/j.molcel.2010.02.001 20227362
37. The biogenesis and function of PIWI proteins and piRNAs: progress and prospect. T Thomson H Lin, Annu Rev Cell Dev Biol 2009 25 355 376 10.1146/annurev.cellbio.24.110707.175327 19575643
38. The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. AA Aravin GJ Hannon J Brennecke, Science 2007 318 761 764 10.1126/science.1146484 17975059 (Pubitemid 351411762)
39. A novel class of small RNAs in mouse spermatogenic cells. ST Grivna E Beyret Z Wang H Lin, Genes Dev 2006 20 1709 1714 10.1101/gad.1434406 16766680 (Pubitemid 43992878)
40. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. J Brennecke AA Aravin A Stark M Dus M Kellis R Sachidanandam GJ Hannon, Cell 2007 128 1089 1103 10.1016/j.cell.2007.01.043 17346786 (Pubitemid 46427877)
41. A slicer-mediated mechanism for repeat-associated siRNA 5 ' end formation in Drosophila. LS Gunawardane K Saito KM Nishida K Miyoshi Y Kawamura T Nagami H Siomi MC Siomi, Science 2007 315 1587 1590 10.1126/science.1140494 17322028 (Pubitemid 46449477)
42. Specialized piRNA Pathways Act in Germline and Somatic Tissues of the Drosophila Ovary. CD Malone J Brennecke M Dus A Stark WR McCombie R Sachidanandam GJ Hannon, Cell 2009 137 522 535 10.1016/j.cell.2009.03.040 19395010
43. A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. AA Aravin R Sachidanandam D Bourc'his C Schaefer D Pezic KF Toth T Bestor GJ Hannon, Molecular Cell 2008 31 785 799 10.1016/j.molcel. 2008.09.003 18922463
44. Biogenesis and germline functions of piRNAs. C Klattenhoff W Theurkauf, Development 2008 135 3 9 10.1242/dev.006486 18032451 (Pubitemid 351201476)
45. Drosophila rasiRNA pathway mutations disrupt embryonic axis specification through activation of an ATR/Chk2 DNA damage response. C Klattenhoff DP Bratu N McGinnis-Schultz BS Koppetsch HA Cook WE Theurkauf, Dev Cell 2007 12 45 55 10.1016/j.devcel.2006.12.001 17199040 (Pubitemid 46002601)
46. Parallel DNA pyrosequencing unveils new zebrafish microRNAs. AR Soares PM Pereira B Santos C Egas AC Gomes J Arrais JL Oliveira GR Moura MA Santos, Bmc Genomics 2009 10 195 10.1186/1471-2164-10-195 19397817
47. Deep sequencing of small RNA libraries reveals dynamic regulation of conserved and novel microRNAs and microRNA-stars during silkworm development. G Jagadeeswaran Y Zheng N Sumathipala HB Jiang EL Arrese JL Soulages WX Zhang R Sunkar, Bmc Genomics 2010 11 - 10.1186/1471-2164-11-52 20089182
48. Most mammalian mRNAs are conserved targets of microRNAs. RC Friedman KKH Farh CB Burge DP Bartel, Genome Research 2009 19 92 105 10.1101/gr.082701.108 18955434
49. MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Q Cui Z Yu Y Pan EO Purisima E Wang, Biochem Biophys Res Commun 2007 352 733 738 10.1016/j.bbrc.2006.11.080 17141185 (Pubitemid 44880316)
50. Combinatorial network of primary and secondary microRNA-driven regulatory mechanisms. K Tu H Yu YJ Hua YY Li L Liu L Xie YX Li, Nucleic Acids Research 2009 37 5969 5980 10.1093/nar/gkp638 19671526
51. Identification of transcription factor and microRNA binding sites in responsible to fetal alcohol syndrome. G Wang X Wang Y Wang JY Yang L Li KP Nephew HJ Edenberg FC Zhou Y Liu, Bmc Genomics 2008 9 Suppl 1 19 10.1186/1471-2164-9-S1-S19 18366608
52. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Y Chen DH Gorski, Blood 2008 111 1217 1226 10.1182/blood-2007-07-104133 17957028 (Pubitemid 351213403)
53. MicroRNA fingerprints during human megakaryocytopoiesis. R Garzon F Pichiorri T Palumbo R Iuliano A Cimmino R Aqeilan S Volinia D Bhatt H Alder G Marcucci,, et al. Proceedings of the National Academy of Sciences of the United States of America 2006 103 5078 5083 10.1073/pnas.0600587103 16549775
54. Increased levels and activity of E2F1 transcription factor in myelodysplastic bone marrow. G Saberwal S Lucas I Janssen A Deobhakta WY Hu N Galili A Raza SD Mundle, Int J Hematol 2004 80 146 154 10.1532/IJH97.NA0303 15481443 (Pubitemid 39201568)
55. Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes. G Saberwal E Broderick I Janssen V Shetty S Alvi L Lisak P Venugopal A Raza SD Mundle, J Hematother Stem Cell Res 2003 12 443 450 10.1089/152581603322286079 12965081 (Pubitemid 36993432)
56. The AP-2 family of transcription factors. D Eckert S Buhl S Weber R Jäger H Schorle, Genome Biology 2005 6 10.1186/gb-2005-6-13-246 16420676
57. Gene Ontology: tool for the unification of biology. M Ashburner CA Ball JA Blake D Botstein H Butler JM Cherry AP Davis K Dolinski SS Dwight JT Eppig,, et al. Nature Genetics 2000 25 25 29 10.1038/75556 10802651 (Pubitemid 30257031)